Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
7
370Ṁ783
2027
19%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against pancreatic adenocarcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy